Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Tohoku University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Tohoku University
ClinicalTrials.gov Identifier:
NCT00418041
First received: January 3, 2007
Last updated: March 31, 2010
Last verified: March 2010
  Purpose

Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) is a large, prospective, hospital-based cohort study to investigate the following:

  • Characteristics of patients with chronic heart failure and prognostic risks of these patients.
  • Characteristics of patients with high risk for heart failure and critical factors which predict the development of symptomatic heart failure in these patients.
  • The incidence and prognostic impact of metabolic syndrome in patients with chronic heart failure.
  • The association between metabolic syndrome and the development of symptomatic heart failure.

Condition
Heart Failure
Coronary Disease
Heart Valve Diseases
Cardiomyopathies
Left Ventricular Hypertrophy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

Resource links provided by NLM:


Further study details as provided by Tohoku University:

Estimated Enrollment: 10000
Study Start Date: October 2006
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients in teaching hospitals

Criteria

Inclusion Criteria:

  • Structural heart disease but without signs or symptoms of heart failure.
  • Structural heart disease with prior or current symptoms of heart failure.
  • Refractory heart failure requiring specialized interventions.
  • Patients with prior cardiovascular surgery or percutaneous coronary intervention and those who need such interventions.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00418041

Locations
Japan
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Sendai-city, Japan, 980-8574
Sponsors and Collaborators
Tohoku University
Investigators
Study Chair: Hiroaki Shimokawa, MD, PhD Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  More Information

Additional Information:
No publications provided by Tohoku University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Hiroaki Shimokawa, Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
ClinicalTrials.gov Identifier: NCT00418041     History of Changes
Other Study ID Numbers: 2006-115
Study First Received: January 3, 2007
Last Updated: March 31, 2010
Health Authority: Japan: Ministry of Health, Labor and Welfare

Additional relevant MeSH terms:
Coronary Disease
Coronary Artery Disease
Heart Failure
Heart Valve Diseases
Hypertrophy
Hypertrophy, Left Ventricular
Cardiomyopathies
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Pathological Conditions, Anatomical
Cardiomegaly

ClinicalTrials.gov processed this record on April 17, 2014